\-\ Texto\\:\\ \ \(0\)\
\-\ large\\ left\\ scrotal\\ mass\\.\ \(0\)\
\-\ ultrasound\\ show\\ as\\ large\\ complex\\ left\\ extratesticular\\ mass\\ with\\ dramatic\\ blood\\ flow\\.\\ \\ contrast\\ enhanced\\ axial\\ ct\\ images\\ show\\ a\\ mixed\\ attenuation\\ left\\ scrotal\\ mass\\ and\\ retroperitoneal\\ adenopathy\\.\ \(0\)\
\-\ scrotal\\ rhabdomyosarcoma\ \(0\)\
\-\ extratesticular\\ masses\\:\ \(0\)\
\-\ adenomatoid\\ tumor\\ \ \(2\)\
\-\ scrotal\\ hematoma\ \(1\)\
\-\ lymphoma\ \(373\)\
\-\ pseudotumor\ \(52\)\
\-\ scrotal\\ mesothelioma\ \(0\)\
\-\ sarcoma\\ \\(rhabdomyosarcoma\\)\ \(0\)\
\-\ 11\\ year\\ old\\ male\\ with\\ a\\ left\\ scrotal\\ mass\\.\ \(1\)\
\-\ while\\ in\\ playing\\ the\\ odds\\,\\ most\\ extratesticular\\ masses\\ are\\ benign\\,\\ given\\ the\\ large\\ size\\ and\\ heterogeneity\\,\\ this\\ doesn\\'t\\ have\\ the\\ appearance\\ of\\ a\\ non\\-aggressive\\ process\\.\\ \\ since\\ there\\ is\\ internal\\ blood\\ flow\\,\\ this\\ isn\\'t\\ a\\ hematoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ scrotal\\:\\ 0\\.2915952870157463\ \(0\)\
\-\ extratesticular\\:\\ 0\\.20260843138668586\ \(0\)\
\-\ n\\'t\\:\\ 0\\.103490984990026\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.09246510074488515\ \(0\)\
\-\ odds\\:\\ 0\\.07420102053171528\ \(0\)\
\-\ heterogeneity\\:\\ 0\\.059389048984146535\ \(0\)\
\-\ hematoma\\:\\ 0\\.058480132277347885\ \(0\)\
\-\ masses\\:\\ 0\\.05554985380761707\ \(0\)\
\-\ flow\\:\\ 0\\.054308728401125314\ \(0\)\
\-\ non\\-aggressive\\:\\ 0\\.05420639032325531\ \(0\)\
\-\ large\\:\\ 0\\.053900262456665765\ \(0\)\
\-\ adenomatoid\\:\\ 0\\.05343674890331746\ \(0\)\
\-\ dramatic\\:\\ 0\\.05307386113425163\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.0514402165496805\ \(0\)\
\-\ show\\:\\ 0\\.05044530643253127\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.047541513587102\ \(0\)\
\-\ mass\\:\\ 0\\.04571003872875248\ \(0\)\
\-\ blood\\:\\ 0\\.0448540590867173\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.04377729372043445\ \(0\)\
\-\ playing\\:\\ 0\\.04377729372043445\ \(0\)\
\-\ 11\\:\\ 0\\.03759849659161605\ \(0\)\
\-\ left\\:\\ 0\\.0367732795874198\ \(0\)\
\-\ adenopathy\\:\\ 0\\.036585414710290795\ \(0\)\
\-\ sarcoma\\:\\ 0\\.036585414710290795\ \(0\)\
\-\ mixed\\:\\ 0\\.03608580183595703\ \(0\)\
\-\ enhanced\\:\\ 0\\.03515829927646125\ \(0\)\
\-\ attenuation\\:\\ 0\\.03303481798486576\ \(0\)\
\-\ complex\\:\\ 0\\.03290279690013593\ \(0\)\
\-\ process\\:\\ 0\\.03163524504648764\ \(0\)\
\-\ since\\:\\ 0\\.030180429054790545\ \(0\)\
\-\ benign\\:\\ 0\\.0283562535291654\ \(0\)\
\-\ given\\:\\ 0\\.028167446081887912\ \(0\)\
\-\ does\\:\\ 0\\.028034817984461603\ \(0\)\
\-\ size\\:\\ 0\\.027546883378642036\ \(0\)\
\-\ internal\\:\\ 0\\.027546883378642036\ \(0\)\
\-\ while\\:\\ 0\\.025852396537041477\ \(0\)\
\-\ ultrasound\\:\\ 0\\.02437617870198369\ \(0\)\
\-\ appearance\\:\\ 0\\.023499101699371555\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02348267917682198\ \(0\)\
\-\ axial\\:\\ 0\\.02344991803911415\ \(0\)\
\-\ tumor\\:\\ 0\\.019156079823180877\ \(0\)\
\-\ most\\:\\ 0\\.01896956867046227\ \(0\)\
\-\ this\\:\\ 0\\.018483407948348712\ \(0\)\
\-\ contrast\\:\\ 0\\.018392073911614477\ \(0\)\
\-\ have\\:\\ 0\\.017792673830433575\ \(0\)\
\-\ images\\:\\ 0\\.01576215280720533\ \(0\)\
\-\ a\\:\\ 0\\.015253838531484666\ \(0\)\
\-\ male\\:\\ 0\\.014857745556610319\ \(0\)\
\-\ as\\:\\ 0\\.012428629864366615\ \(0\)\
\-\ there\\:\\ 0\\.012228034196778738\ \(0\)\
\-\ ct\\:\\ 0\\.011493304359538875\ \(0\)\
\-\ are\\:\\ 0\\.011200710312784632\ \(0\)\
\-\ \\:\\:\\ 0\\.010868027076833318\ \(0\)\
\-\ is\\:\\ 0\\.010813284199706263\ \(0\)\
\-\ \\,\\:\\ 0\\.010411925596818746\ \(0\)\
\-\ year\\:\\ 0\\.00919331989685495\ \(0\)\
\-\ old\\:\\ 0\\.008412832662137064\ \(0\)\
\-\ \\(\\:\\ 0\\.00694578582926789\ \(0\)\
\-\ \\)\\:\\ 0\\.006860939347243318\ \(0\)\
\-\ in\\:\\ 0\\.004051896443656298\ \(0\)\
\-\ the\\:\\ 0\\.003987960135681513\ \(0\)\
\-\ and\\:\\ 0\\.003461711648696509\ \(0\)\
\-\ with\\:\\ 0\\.0022500803094209565\ \(0\)\
\-\ \\.\\:\\ 0\\.002048050159462285\ \(0\)\
\-\ of\\:\\ 0\\.0011202288538268118\ \(0\)\
